Novartis tests copy of Amgen's Enbrel in late-stage trial

[riky]

Novartis tests copy of Amgen's Enbrel in late-stage trial

<p><a href="http://news.yahoo.com/novartis-tests-copy-amgens-enbrel-stage-trial-062548284.html"><img src="http://l3.yimg.com/bt/api/res/1.2/IXDwdsaMDCe6FlspOIhxeQ--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3E9ODU7dz0xMzA-/http://media.zenfs.com/en_us/News/Reuters/2013-06-24T062548Z_1_CBRE95N0HV400_RTROPTP_2_INDIA-NOVARTIS-PATENTS.JPG" width="130" height="86" alt="A Novartis logo is pictured on its headquarters building in Mumbai" align="left" title="A Novartis logo is pictured on its headquarters building in Mumbai" border="0" /></a>LONDON (Reuters) - Sandoz, the generics unit of Novartis, has launched a late-stage trial with its biosimilar version of Amgen's Enbrel, consolidating its leading position in developing cheaper copies of complex biotech drugs. With the start of the major study of its version of Enbrel, or etanercept, Sandoz now has seven Phase III clinical trials across five biosimilar molecules - more than any other company in the industry. Sandoz said on Monday the new trial aimed to confirm the biosimilarity of its product versus Enbrel in patients with moderate to severe chronic plaque-type psoriasis. ...</p><br clear="all"/>

Source: You are not allowed to view links. Register or Login